175 related articles for article (PubMed ID: 31611818)
1. Syndecans and Enzymes for Heparan Sulfate Biosynthesis and Modification Differentially Correlate With Presence of Inflammatory Infiltrate in Periodontitis.
Duplancic R; Roguljic M; Puhar I; Vecek N; Dragun R; Vukojevic K; Saraga-Babic M; Kero D
Front Physiol; 2019; 10():1248. PubMed ID: 31611818
[TBL] [Abstract][Full Text] [Related]
2. Syndecans and Enzymes Involved in Heparan Sulfate Biosynthesis and Degradation Are Differentially Expressed During Human Odontogenesis.
Kero D; Bilandzija TS; Arapovic LL; Vukojevic K; Saraga-Babic M
Front Physiol; 2018; 9():732. PubMed ID: 29962964
[TBL] [Abstract][Full Text] [Related]
3. Syndecans as modulators and potential pharmacological targets in cancer progression.
Barbouri D; Afratis N; Gialeli C; Vynios DH; Theocharis AD; Karamanos NK
Front Oncol; 2014; 4():4. PubMed ID: 24551591
[TBL] [Abstract][Full Text] [Related]
4. Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans.
Duplancic R; Roguljic M; Bozic D; Kero D
Bioengineering (Basel); 2022 Oct; 9(10):. PubMed ID: 36290535
[TBL] [Abstract][Full Text] [Related]
5. An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population.
Okolicsanyi RK; Bluhm J; Miller C; Griffiths LR; Haupt LM
Hum Genomics; 2020 May; 14(1):18. PubMed ID: 32398079
[TBL] [Abstract][Full Text] [Related]
6. Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.
Agere SA; Kim EY; Akhtar N; Ahmed S
J Cell Physiol; 2018 Sep; 233(9):6346-6358. PubMed ID: 29226950
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycans in glomerular inflammation.
Rops AL; van der Vlag J; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH
Kidney Int; 2004 Mar; 65(3):768-85. PubMed ID: 14871397
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.
Crespo A; García-Suárez O; Fernández-Vega I; Solis-Hernandez MP; García B; Castañón S; Quirós LM
BMC Cancer; 2018 Jun; 18(1):687. PubMed ID: 29940912
[TBL] [Abstract][Full Text] [Related]
9. In vivo activities of heparan sulfate differentially modified by NDSTs during development.
Nakato E; Baker S; Kinoshita-Toyoda A; Knudsen C; Lu YS; Takemura M; Toyoda H; Nakato H
Proteoglycan Res; 2024 Jan; 2(1):. PubMed ID: 38616954
[TBL] [Abstract][Full Text] [Related]
10. Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
O'Callaghan P; Zhang X; Li JP
J Histochem Cytochem; 2018 Apr; 66(4):305-319. PubMed ID: 29290138
[TBL] [Abstract][Full Text] [Related]
11. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.
Nagarajan A; Malvi P; Wajapeyee N
Front Endocrinol (Lausanne); 2018; 9():483. PubMed ID: 30197623
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes.
Grobe K; Ledin J; Ringvall M; Holmborn K; Forsberg E; Esko JD; Kjellén L
Biochim Biophys Acta; 2002 Dec; 1573(3):209-15. PubMed ID: 12417402
[TBL] [Abstract][Full Text] [Related]
13. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
14. Implications of heparan sulfate and heparanase in neuroinflammation.
Zhang X; Wang B; Li JP
Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
[TBL] [Abstract][Full Text] [Related]
15. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.
Fernández-Vega I; García-Suárez O; García B; Crespo A; Astudillo A; Quirós LM
BMC Cancer; 2015 Oct; 15():742. PubMed ID: 26482785
[TBL] [Abstract][Full Text] [Related]
17. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
18. Syndecans in inflammation.
Götte M
FASEB J; 2003 Apr; 17(6):575-91. PubMed ID: 12665470
[TBL] [Abstract][Full Text] [Related]
19. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
Lanzi C; Zaffaroni N; Cassinelli G
Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of periodontitis: role of cytokines in host response.
Deo V; Bhongade ML
Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
